Showing all published months. Partner preview tables include up to 5 countries.
USD value by month, all available partner countries combined
Free partner preview shows up to 5 countries.
Total value across the selected data period
| Partner | Value | Share |
|---|---|---|
| Brazil | $332.2M | 12.0% |
| India | $321.7M | 11.7% |
| Germany | $157.1M | 5.7% |
| Hong Kong | $129.8M | 4.7% |
| Pakistan | $128.1M | 4.6% |
Availability is confirmed when the API response loads.
| Partner | Value | Share |
|---|---|---|
| India | $5.8M | 21.8% |
| Pakistan | $2.4M | 8.9% |
| Argentina | $1.6M | 5.9% |
| Indonesia | $1.4M | 5.2% |
| Egypt | $1.3M | 4.7% |
| Year | Export value |
|---|---|
| 2021 | $460.3M |
| 2022 | $516.6M |
| 2023 | $463.9M |
| 2024 | $475.6M |
| 2025 | $502.1M |
| 2026 | $343M |
China customs reports HS 300320 at the 8-digit level. 9 subheadings are published under it, and export values for each are available on request.
Bulk antibiotic formulations based on cefotaxime are supplied for further processing or institutional dispensing rather than individual retail use.
Institutional or bulk-quantity medicines utilizing ceftazidime as the active antibiotic component are traded without measured retail packaging.
Antibiotic treatments containing cefuroxime are provided in bulk quantities intended for repackaging or pharmaceutical manufacturing instead of retail doses.
Ceftriaxone-based antibiotic medicines are distributed in bulk, non-retail formats suitable for further formulation or large-scale dispensing operations.
Pharmaceutical preparations featuring cefoperazone are handled in bulk amounts for subsequent processing, distinct from pre-measured consumer packages.
Bulk antibiotic products derived from other cephamycin compounds not otherwise specified are traded for manufacturing or institutional use without retail dosing.
Bulk antibiotic medicines not individually dosed or retail-packaged, encompassing formulations not classified elsewhere and typically supplied for further pharmaceutical…
Public data shows up to 5 partner countries. Request all available countries, years, quantity fields, or HS8 detail in CSV.
HS 300320 is also written 3003.20. Values are in USD; the public series does not report tonnes or kg. Product scope: Antibiotic-containing medicines supplied in bulk quantities rather than individual retail doses, typically traded for further pharmaceutical processing, repackaging, or institutional dispensing. The public page shows monthly export partner previews from official GACC customs statistics. Full partner-month rows are available through a scoped custom data request.
Source: China General Administration of Customs (GACC), cleaned and structured by China Data Portal.
Transformations: Values are presented as published by the source.
China Data Portal. "China Medicaments (HS 300320) Export Data." https://chinadata.live/china-trade/hs/300320/
HS 300320 is also written 3003.20. Values are in USD; the public series does not report tonnes or kg. Product scope: Antibiotic-containing medicines supplied in bulk quantities rather than individual retail doses, typically traded for further pharmaceutical processing, repackaging, or institutional dispensing. The public page shows monthly export partner previews from official GACC customs statistics. Full partner-month rows are available through a scoped custom data request.
Source: China General Administration of Customs (GACC), cleaned and structured by China Data Portal.
Transformations: Values are presented as published by the source.
China Data Portal. "China Medicaments (HS 300320) Export Data." https://chinadata.live/china-trade/hs/300320/
China exported $512M of medicaments in the twelve months to August 2026, averaging $42.7M per month, based on official China customs statistics (HS 300320).
Antibiotic-containing medicines supplied in bulk quantities rather than individual retail doses, typically traded for further pharmaceutical processing, repackaging, or institutional dispensing.
Brazil, India and Germany together account for 29% of the published total, out of 68 trading partners on record.
Annual exports grew by 9% between 2021 and 2025, from $460M to $502M.
Figures come from official China General Administration of Customs (GACC) statistics, published monthly. ChinaData cleans partner names, periods and values so the series is ready for analysis. Partner-level rows for every month, including HS8 detail, are available on request.